Amy E. Mercer

1.0k total citations
15 papers, 806 citations indexed

About

Amy E. Mercer is a scholar working on Public Health, Environmental and Occupational Health, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Amy E. Mercer has authored 15 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Public Health, Environmental and Occupational Health, 5 papers in Organic Chemistry and 5 papers in Molecular Biology. Recurrent topics in Amy E. Mercer's work include Malaria Research and Control (10 papers), Computational Drug Discovery Methods (4 papers) and HIV/AIDS drug development and treatment (4 papers). Amy E. Mercer is often cited by papers focused on Malaria Research and Control (10 papers), Computational Drug Discovery Methods (4 papers) and HIV/AIDS drug development and treatment (4 papers). Amy E. Mercer collaborates with scholars based in United Kingdom, Netherlands and United States. Amy E. Mercer's co-authors include Paul M. O’Neill, James L. Maggs, James Chadwick, B. Kevin Park, Stephen A. Ward, Ian M. Copple, B. Kevin Park, Xiaoming Sun, Gerald M. Cohen and Paul A. Stocks and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Journal of Medicinal Chemistry.

In The Last Decade

Amy E. Mercer

15 papers receiving 789 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy E. Mercer United Kingdom 13 344 316 226 161 137 15 806
B. Kevin Park United Kingdom 12 297 0.9× 212 0.7× 212 0.9× 142 0.9× 76 0.6× 15 587
Tony Fröhlich Germany 16 293 0.9× 381 1.2× 431 1.9× 116 0.7× 161 1.2× 18 1.0k
Christine Latour France 17 289 0.8× 152 0.5× 331 1.5× 88 0.5× 59 0.4× 23 747
Burkhard Fugmann Germany 16 261 0.8× 167 0.5× 310 1.4× 136 0.8× 88 0.6× 25 784
Aysun Çapcı Germany 15 172 0.5× 342 1.1× 358 1.6× 73 0.5× 106 0.8× 19 754
Falgun Shah United States 18 133 0.4× 277 0.9× 131 0.6× 254 1.6× 74 0.5× 22 712
Shaun R. Hawley United Kingdom 15 615 1.8× 219 0.7× 284 1.3× 201 1.2× 107 0.8× 23 983
Kristina Borstnik United States 10 352 1.0× 172 0.5× 257 1.1× 170 1.1× 94 0.7× 10 606
Francesca Blasco Switzerland 14 98 0.3× 426 1.3× 222 1.0× 82 0.5× 86 0.6× 20 897
David Waterson Switzerland 20 331 1.0× 393 1.2× 523 2.3× 178 1.1× 129 0.9× 38 1.2k

Countries citing papers authored by Amy E. Mercer

Since Specialization
Citations

This map shows the geographic impact of Amy E. Mercer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy E. Mercer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy E. Mercer more than expected).

Fields of papers citing papers by Amy E. Mercer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy E. Mercer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy E. Mercer. The network helps show where Amy E. Mercer may publish in the future.

Co-authorship network of co-authors of Amy E. Mercer

This figure shows the co-authorship network connecting the top 25 collaborators of Amy E. Mercer. A scholar is included among the top collaborators of Amy E. Mercer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy E. Mercer. Amy E. Mercer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Copple, Ian M., Amy E. Mercer, James W. Firman, et al.. (2012). Examination of the Cytotoxic and Embryotoxic Potential and Underlying Mechanisms of Next-Generation Synthetic Trioxolane and Tetraoxane Antimalarials. Molecular Medicine. 18(7). 1045–1055. 11 indexed citations
2.
Mercer, Amy E., et al.. (2011). The pharmacokinetic evaluation of artemisinin drugs for the treatment of malaria in paediatric populations. Expert Opinion on Drug Metabolism & Toxicology. 7(4). 427–439. 7 indexed citations
3.
Amewu, Richard K., Peter Gibbons, Andrew V. Stachulski, et al.. (2010). Synthesis, in vitro and in vivo antimalarial assessment of sulfide, sulfone and vinyl amide-substituted 1,2,4-trioxanes prepared via thiol-olefin co-oxygenation (TOCO) of allylic alcohols. Organic & Biomolecular Chemistry. 8(9). 2068–2068. 13 indexed citations
4.
Chadwick, James, Michael E. Jones, Amy E. Mercer, et al.. (2010). Design, synthesis and antimalarial/anticancer evaluation of spermidine linked artemisinin conjugates designed to exploit polyamine transporters in Plasmodium falciparum and HL-60 cancer cell lines. Bioorganic & Medicinal Chemistry. 18(7). 2586–2597. 46 indexed citations
5.
Mercer, Amy E., Ian M. Copple, James L. Maggs, Paul M. O’Neill, & B. Kevin Park. (2010). The Role of Heme and the Mitochondrion in the Chemical and Molecular Mechanisms of Mammalian Cell Death Induced by the Artemisinin Antimalarials. Journal of Biological Chemistry. 286(2). 987–996. 127 indexed citations
6.
Antoine, Daniel J., Amy E. Mercer, Dominic P. Williams, & B.K. Park. (2009). Mechanism-based bioanalysis and biomarkers for hepatic chemical stress. Xenobiotica. 39(8). 565–577. 33 indexed citations
7.
Mercer, Amy E., Sophie Regan, Daniel J. Antoine, et al.. (2009). Functional and toxicological consequences of metabolic bioactivation of methapyrilene via thiophene S-oxidation: Induction of cell defence, apoptosis and hepatic necrosis. Toxicology and Applied Pharmacology. 239(3). 297–305. 21 indexed citations
8.
Jones, Michael E., Amy E. Mercer, Paul A. Stocks, et al.. (2009). Antitumour and antimalarial activity of artemisinin–acridine hybrids. Bioorganic & Medicinal Chemistry Letters. 19(7). 2033–2037. 48 indexed citations
9.
Mercer, Amy E.. (2009). The role of bioactivation in the pharmacology and toxicology of the artemisinin-based antimalarials.. PubMed. 12(1). 125–32. 18 indexed citations
10.
Chadwick, James, Amy E. Mercer, B. Kevin Park, Richard Cosstick, & Paul M. O’Neill. (2008). Synthesis and biological evaluation of extraordinarily potent C-10 carba artemisinin dimers against P. falciparum malaria parasites and HL-60 cancer cells. Bioorganic & Medicinal Chemistry. 17(3). 1325–1338. 56 indexed citations
11.
Stocks, Paul A., Patrick G. Bray, Victoria Barton, et al.. (2007). Evidence for a Common Non‐Heme Chelatable‐Iron‐Dependent Activation Mechanism for Semisynthetic and Synthetic Endoperoxide Antimalarial Drugs. Angewandte Chemie International Edition. 46(33). 6278–6283. 116 indexed citations
12.
Mercer, Amy E., James L. Maggs, Xiaoming Sun, et al.. (2007). Evidence for the Involvement of Carbon-centered Radicals in the Induction of Apoptotic Cell Death by Artemisinin Compounds. Journal of Biological Chemistry. 282(13). 9372–9382. 169 indexed citations
13.
Stocks, Paul A., Patrick G. Bray, Victoria Barton, et al.. (2007). Evidence for a Common Non‐Heme Chelatable‐Iron‐Dependent Activation Mechanism for Semisynthetic and Synthetic Endoperoxide Antimalarial Drugs. Angewandte Chemie. 119(33). 6394–6399. 23 indexed citations
14.
Posner, Gary H., John G. D’Angelo, Paul M. O’Neill, & Amy E. Mercer. (2006). Anticancer activity of artemisinin-derived trioxanes. Expert Opinion on Therapeutic Patents. 16(12). 1665–1672. 37 indexed citations
15.
Bray, Patrick G., James Chadwick, Amy E. Mercer, et al.. (2004). Antimalarial and Antitumor Evaluation of Novel C-10 Non-Acetal Dimers of 10β-(2-Hydroxyethyl)deoxoartemisinin. Journal of Medicinal Chemistry. 47(5). 1290–1298. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. Kevin Park Breakdown of academic impact, for papers by Tony Fröhlich Breakdown of academic impact, for papers by Christine Latour Breakdown of academic impact, for papers by Burkhard Fugmann Breakdown of academic impact, for papers by Aysun Çapcı Breakdown of academic impact, for papers by Falgun Shah Breakdown of academic impact, for papers by Shaun R. Hawley Breakdown of academic impact, for papers by Kristina Borstnik Breakdown of academic impact, for papers by Francesca Blasco Breakdown of academic impact, for papers by David Waterson
Rankless by CCL
2026